Specific inhibition of PP2A/Bα is associated with enhanced tau phosphorylation at many AD-like phosphoepitopes, and subsequent inability of tau to bind to and stabilize microtubules (Sontag et al., 1996). The gene discussed is MAPT; the disease is Alzheimer disease.